Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial
Recruiting now NCT05142683
Run by Centre for Addiction and Mental Health · for 13 to 18 · All sexes · accepts healthy volunteers
What this study is about
This is a quasi-experimental, multi-site cluster controlled clinical trial design with two intervention arms--Treatment As Usual (TAU) and an Integrated Care Pathway (ICP). Eligible participants are between the ages of 13 and 18, who present to community mental health agencies with depressive symptoms as the primary concern. The primary clinical outcome of interest is the difference between treatment groups in the rate of change of depressive symptoms from baseline to 24-week endpoint as measured by the Mood and Feelings Questionnaire. The secondary outcomes include rate of change of functional improvement, as measured by the Childhood Anxiety and Depression Life Interference Scale, and caregiver-rated internalizing symptoms as rated by the Childhood Behaviour Checklist. This study will also be examining implementation outcomes such as feasibility, fidelity cost and acceptability.
Who can join (things the study team will check)
✅ You may be able to join if…
- Youth is aged 13 to 18 years, inclusive.
- Youth and/or their caregiver is expressing that 'depression" (or some synonym) is a concern.
- Clinician agrees that depressive symptoms are a treatment target.
- Mood and Feelings Questionnaire score is ≥22 at two sequential visits (screening and baseline assessment).
- Youth must be new to the site (in past 3 months) or have a period of no treatment for 3 months
🚫 You may not be able to join if…
- Known or highly suspected presentations of psychotic symptoms that are persistent, affect functioning, and have observable effects on behaviour.
- Severe substance use disorder, bipolar disorder, autism spectrum disorder or intellectual disability, severe eating disorder, imminent risk of suicide requiring hospitalization as per judgment of the assessing clinician.
- Inability to provide informed consent to the study for any reason
- Youth currently in Day Treatment
Where this trial is running
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Who to contact
Darren B Courtney, MD · 800-463-2338 · dr.courtney.research@gmail.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05142683.
Verify everything on the official ClinicalTrials.gov record. Page updated September 2026.